New Filings & Updated Terms (8.24.18)

This is the latest look at the IPO Pipeline including the newest filings that have registered with the SEC in the last seven days.

IPO Boutique keeps apprised of the active pipeline. Currently there are 65 active IPOs in the pipeline as of August 24, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why “looks may be perceiving” when it comes to the IPO pipeline in this article.

NEW FILINGS

 

Company: Zekelman Industries, Inc.
Symbol: ZEK
Description: They are a leading North American manufacturer of industrial steel pipe and tube products with over 100 years of operating experience.
New York.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Goldman Sachs & Co., BofA Merrill Lynch
Co-Manager(s): BMO Capital Markets, Credit Suisse, GMP Securities, KeyBanc Capital Markets, William Blair, Stifel, BTIG, PNC Capital Markets LLC
Filed: 8-17-18
Listed Cash Raise: $100m

Company: Principia Biopharma Inc.
Symbol: PRNB
Description: They are a clinical-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with significant unmet medical needs in immunology and oncology.
New York.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): BofA Merrill Lynch, Leerink, Wells Fargo
Co-Manager(s): Baird
Filed:8-17-18
Listed Cash Raise: $86.25m

Company: Qutoutiao Inc.
Symbol: QTT
Description: They are the No. 2 mobile content aggregator in China in terms of MAUs and average DAUs in July 2018, according to the Analysys Report.
New York.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Citigroup, Deutsche Bank Securities, China Merchants Securities, UBS Investment Bank
Co-Manager(s): KeyBanc Capital
Filed:8-17-18
Listed Cash Raise: $300m

Company: Entasis Therapeutics Holdings Inc.
Symbol: ETTX
Description: They are a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel antibacterial products to treat serious infections caused by multi-drug resistant Gram-negative bacteria.
New York.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Credit Suisse, BMO Capital Markets
Co-Manager(s): SunTrust Robinson Humphrey, Wedbush PacGrow
Filed:8-17-18
Listed Cash Raise: $86.25m

Company: Farfetch Limited
Symbol: FTCH
Description: Farfetch is the leading technology platform for the global luxury fashion industry.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Goldman Sachs & Co., J.P. Morgan, Allen & Company, UBS Investment Bank, Credit Suisse ,Deutsche Bank Securities, Wells Fargo Securities
Co-Manager(s): Cowen, BNP PARIBAS
Filed:8-20-18
Listed Cash Raise: $100m

Company: FVCBankcorp, Inc.
Symbol: FVCB
Description: FVCBankcorp, Inc. is the registered bank holding company for FVCbank, their wholly-owned community bank subsidiary, headquartered in Fairfax, Virginia.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Sandler O’ Neill + Partners, Raymond James
Filed:8-20-18
Listed Cash Raise: $40.25m

Company: Gritstone Oncology, Inc.
Symbol: GRTS
Description: They are an immuno-oncology company developing tumor-specific cancer immunotherapies to fight multiple cancer types.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Goldman Sachs, Cowen, Barclays
Co-Manager(s): BTIG
Filed:8-23-18
Listed Cash Raise: $80m

Company: Eventbrite, Inc.
Symbol: EB
Description: They founded Eventbrite to bring the world together through live experiences.
Trade Date: TBD
Shares: TBD
Price Range: TBD
Underwriter(s): Goldman Sachs, J.P. Morgan, Allen & Co., RBC Capital, SunTrust Robinson Humphrey, Stifel
Filed:8-23-18
Listed Cash Raise: $200m

TERMS ADDED

NONE THIS WEEK